Premium
MR Spectroscopy Findings in Lafora Disease
Author(s) -
Altindag Ebru,
Kara Batuhan,
Baykan Betul,
Terzibasioglu Ege,
Sencer Serra,
Onat Levent,
Sı Mustafa
Publication year - 2009
Publication title -
journal of neuroimaging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.822
H-Index - 64
eISSN - 1552-6569
pISSN - 1051-2284
DOI - 10.1111/j.1552-6569.2008.00325.x
Subject(s) - cerebellum , medicine , pons , progressive myoclonus epilepsy , lafora disease , myoclonus , frontal lobe , ataxia , cerebellar ataxia , gastroenterology , pathology , disease , psychiatry , genetics , biology , phosphorylation , phosphatase
PURPOSE Our aim was to investigate the [ 1 H] MR spectroscopy (MRS) findings of Lafora Disease (LD), which is a disabling form of progressive myoclonic epilepsy.METHODS Twelve patients diagnosed with LD and 12 control subjects underwent MRS studies with single‐voxels of 8 cc obtained in the frontal lobe, pons, and cerebellum. The metabolites and NAA/Cr, NAA/Cho, Cho/Cr, mI/Cr ratios were calculated. Subgroup analysis was also done between 5 patients with EPM2B and 6 patients with EPM2A mutations. Two investigators scored neurological symptom severity.RESULTS We found a statistically significant difference of NAA/Cho ratio in LD patients compared with normal controls in cerebellum ( P = 0.04). In addition, both myoclonus and ataxia scores showed significant correlation with NAA/Cho ratios in the pons ( P = 0.03, P = 0.04) and in the cerebellum ( P = 0.04, P = 0.01), respectively.CONCLUSION We conclude that the cerebellum is the mostly affected structure in LD and there are significant correlations of MRS findings with some clinical parameters. The differences in the group may be related to different genetic mutations besides disease duration and other clinical variables. MRS studies could provide insights about the severity of the involvement of LD.